Join us Sept. 14-16 in Miami to connect with top publishing leaders
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Instacart launches custom AI assistants for retailers
Retail giants like Walmart, Kroger and Amazon have launched AI assistants allowing consumers to ask for recommendations or curated shopping lists. Now, Instacart has made it easier for other retailers such as regional grocers to follow in their footsteps.
AI reshapes agency economics, but their contracts are still scrambling to catch up
AI is changing agency work. Agencies are adding provisions to existing contracts instead of rewriting their MSAs.
Ad Tech Briefing: Regulatory storm clouds gather and scatter over Big Tech, and indies count the cost
The FTC’s Amazon charges presage Google’s second antitrust let-off in a year, while The Trade Desk sheds hundreds.